Where Innovation Meets National Impact

360Disruption is where U.S. innovation, GCC execution, and African-scale deployment converge to build sovereign health and technology ecosystems.

We don’t consult — we incubate, accelerate, and commercialize breakthrough solutions, transforming them into national programs through government partnerships, clinical integration, localized manufacturing, and AI-enabled infrastructure.

Our three pillars connect global innovators with the GCC’s and Africa’s long-term development goals:

🧬 Life Sciences & Diagnostics

HealthTech • Biotech • Molecular Diagnostics • Longevity • National Screening
We build sovereign diagnostic ecosystems — from saliva-based testing to population health intelligence — enabling early detection, health resilience, and data independence.

🌱 Sustainability & Advanced Manufacturing

Green Chemistry • Circular Economy • Local Production • Technology Transfer
We help nations localize manufacturing, reduce dependency, and build new industries that create jobs and economic value.

🤖 AI & Digital Transformation

AI Health Platforms • Industry 4.0 • Smart Supply Chains • Digital Workflows
We integrate AI-driven systems that connect diagnostics, telehealth, logistics, and national infrastructure into unified, intelligent networks.

Together, these pillars deliver:

• Foreign direct investment

• Job creation & industrial diversification

• Technology transfer & sovereign capability

• Health outcomes that scale across nations

This is how 360Disruption helps governments and innovators build the next generation of industries — across the GCC, Africa, and beyond.

🚀360DISRUPTION.COM

From North America to the Gulf and Africa – We Turn Vision into Velocity

A Global Commercialization Engine for High-Impact Health & Innovation

We help innovators, governments, and investors move faster by combining U.S. technologies, GCC market expertise, and African deployment capability into a single, integrated platform.

OUR CORE PILLARS

360Disruption is uniquely positioned at the intersection of innovation, government, and real-world deployment.

🧠Who We Are

A cross-continental execution platform built to transform national health and technology ecosystems.

360Disruption is an execution engine operating at the intersection of U.S. innovation, GCC industrial capability, and Africa’s need for scalable, sovereign health systems.
We bridge the worlds of diagnostics, life sciences, AI, sustainability, and advanced manufacturing — turning breakthrough technologies into national-level programs that improve lives.

We do not advise.
We architect, deploy, and scale.

Our role is to help governments, innovators, and investors build the infrastructure of the future:

• Sovereign diagnostic systems

• Health and biotech commercialization pathways

• Localized manufacturing & technology transfer

• AI-enabled national workflows

• FDI models that create jobs and long-term value

360Disruption was built on a simple belief:
innovation means nothing until it reaches the people who need it.

We partner with Ministries of Health, investment authorities, free zones, clinical organizations, and global innovators to deliver real, measurable national impact across the GCC and Africa.

This is not consulting.
This is execution at continental scale.

This is 360Disruption.

Take your innovation into the GCC and Africa — with a partner who knows the terrain.

💡  What We Do

We build diagnostic ecosystems that countries can depend on.

360Disruption is not a consultancy — we are an execution engine that designs, deploys, and scales diagnostic systems across Africa and the Gulf.
We bring together U.S. innovation, GCC execution capability, and African public-sector partnerships to create sovereign, scalable, population-level health infrastructure.

Below is what we do — and what makes us different:

1. Diagnostic Ecosystem Development

We architect and deploy complete diagnostic pathways tailored to national needs, including saliva-based molecular systems, decentralized sampling, digital reporting, and population health intelligence.
This is diagnostics as infrastructure — built to scale across millions.

2. Government Partnerships & National Deployment Strategy

We work directly with Ministries of Health, Public Health Institutes, Investment Offices, and Free Zones to design:

• regulatory pathways

• national rollout frameworks

• PPP investment models

• long-term sustainability plans

We turn innovation into country-level programs.

3. Localization & Manufacturing Pathways

We help governments move from import-dependence to sovereign diagnostic production by establishing:

• assembly lines for saliva kits and diagnostic devices

• micro-manufacturing ecosystems

• IP-enabled technology transfer models

This drives job creation, economic diversification, and national resilience.

4. Clinical & Telehealth Integration

Through our clinical partners, we bring the digital layer required for nationwide adoption:

• remote clinical oversight

• diagnostic reporting workflows

• telehealth follow-up

• AI-enabled decision support

This connects diagnostics to care — not just to data.

5. FDI Structuring & Public Health Investment

We design investment pathways that align international innovators with national priorities.
This includes:

• foreign direct investment frameworks

• co-investment with public entities

• health sovereignty financing models

• industrial localization packages

We ensure innovations land in the right way, with the right partners, at the right scale.

⭐ The Outcome

Countries gain diagnostic sovereignty, innovators gain market access, and populations gain access to early detection and equitable care.

This is execution, not consulting.
This is 360Disruption.

🚀 Building Diagnostic Sovereignty Across Africa & the Gulf

Health outcomes across Africa and the Gulf depend on one foundational capability: sovereign access to diagnostics. Without local testing capacity, governments remain dependent on foreign labs, slow logistics, and fragile supply chains — delaying treatment, increasing cost, and limiting national resilience.

360Disruption is building the region’s first scalable diagnostic ecosystems, powered by decentralized saliva-based sampling (Oasis Diagnostics), clinical oversight and digital workflow (Oludent Health), and execution at national scale (360Disruption).

We help countries move from importing solutions to owning the infrastructure that protects their population’s long-term health.

Through 360Uncover and our GCC partnerships, we deliver:

• Local testing capabilities where none existed before

• National screening programs for early detection

• Rapid deployment at scale, from rural to urban centers

• FDI-backed manufacturing pathways for sustained growth

• Digital reporting & real-time health intelligence

• Reduced dependency on foreign diagnostics

This is not a pilot.
This is not a consultancy.
This is the foundation of health sovereignty for the next generation.

🚀 Why It Matters

Healthcare inequity across the GCC and Africa is not a technology problem — it’s an execution problem.
We solve that problem by bringing the right innovations, the right partners, and the right implementation strategy to the places that need them most.

Millions across Africa, the Gulf, and remote regions have limited access to diagnostics, early detection, and specialist care.

At the same time, powerful U.S. and European innovations struggle to reach the markets that need them most.

We connect these two worlds.

By bridging innovators with governments, ministries, and national health systems, 360Disruption accelerates:

• early disease detection

• local manufacturing

• job creation

• healthcare modernization

• economic diversification

This is not consultancy.
This is nation-building through innovation.

Our mission is simple:

Make advanced diagnostics, preventive health, and technology-driven care accessible to millions — sustainably and at scale.

🔥Our Impact Areas

💥 Ready to Lead the Market — Not Just Compete?

Let’s build something the world can’t ignore.
Let’s disrupt. Let’s dominate. Let’s make history.

WHERE WE CREATE IMPACT

United States

We source emerging technologies from across diagnostics, AI, biotech, and sustainability — preparing them for regulated international expansion.

GCC 

We commercialize global innovations through free zones, regulatory authorities, hospitals, sovereign investors, and public-private partnerships.

Africa 

We design national screening pilots, telehealth systems, saliva diagnostics hubs, and FDI-led local manufacturing plants — bringing care to regions where it is needed most.

Accelerating Diagnostic Sovereignty Across Africa

360UNCOVER is a flagship initiative of 360Disruption, created by
Anjo De Heus, Dr. Paul Slowey (Oasis Diagnostics Corporation), and
Dr. Oluwadayo Oluwadara (Oludent Health International).

Together, we combine U.S. diagnostic technology, clinical and molecular expertise, and government-level execution to help African nations build sovereign, self-sustaining diagnostic ecosystems.

Our mission is simple:
to move countries from dependency to national capability through decentralized screening, local manufacturing pathways, and scalable, population-level deployment models.

360UNCOVER is not a concept paper or a study.
It is a real, operational pathway—built for implementation, investment, and measurable public health impact.

Read the full story behind this alliance →

💡 Don’t just enter the Gulf or Africa— lead it.

Let us guide your entry, localization, and scale.

🚀 What We Work On

At 360Disruption, we don’t just talk about market entry — we build, launch, and scale ventures. Our focus spans life sciences, sustainable solutions, and AI-powered digital transformation, with real-world projects that demonstrate our Incubate – Accelerate – Commercialize model in action.

⭐ SELECTED PROJECTS (HIGH-LEVEL OVERVIEW)

A snapshot of the work we lead across government, health, and innovation ecosystems.

🇦🇪 UAE – Health Innovation & Commercialization Strategy

Sector: Healthtech, Advanced Diagnostics
Role: Strategy, Commercialization, Government Engagement
Outcome:
We supported the UAE’s transition toward next-generation diagnostics and preventive health by guiding international innovators into the market, structuring partnerships, and aligning technologies with national priorities such as “Make It in the Emirates” and UAE Vision 2031.
This included working with U.S. and GCC partners on localization pathways, regulatory navigation, and public–private engagement.

🌍 Africa – National Diagnostics & Telehealth Ecosystem Development

Countries: All
Sector: Diagnostics, Public Health, FDI, Manufacturing
Role: Country Entry, PPP Structuring, Government Advisory, Market Blueprint
Outcome:
We built a multi-country framework for saliva-based molecular diagnostics, telehealth pathways, and decentralized testing, leveraging partnerships with Oasis Diagnostics and Oludent Health International.
The initiative supports:

• affordable national screening programs

• localized manufacturing

• job creation

• capacity building for health ministries
  This model is currently under government review for rollout.

🇺🇸 / GCC – DeepTech & Advanced Manufacturing Expansion

Sector: AI, Sensors, Biotech, Advanced Materials
Role: Cross-Border Expansion, FDI Strategy, Market Localization
Outcome:
We advise U.S. innovators entering the GCC on market positioning, regulatory pathways, enterprise partnerships, and investment structuring.
This includes AI/diagnostics platforms, micro-sensor technologies, longevity products, and next-gen health manufacturing.
Our work accelerates foreign innovators’ ability to establish commercial, governmental, and industrial footholds across the Gulf.

🇸🇦 Saudi Arabia – Strategy for Innovation & Industrial Growth

Sector: FDI, Advanced Technology, Health & Industry
Role: Market Advisory, Ecosystem Partnerships, Investor Engagement
Outcome:
We crafted entry and partnership strategies enabling companies to align with Saudi Vision 2030, build investor relationships, and position solutions for local deployment.
Our frameworks help companies accelerate government adoption, establish pilot projects, and secure on-ground partnerships.

🌐 Global – Investment Advisory for Transformative Technologies

Sector: Healthtech, Biotech, AI, Diagnostics
Role: Due Diligence, Commercial Strategy, Market Blueprint
Outcome:
We support investors with assessing breakthrough technologies and determining the highest-value path to commercialization across the U.S., GCC, and Africa. Our work bridges scientific validation, commercial design, and government alignment—ensuring technologies scale in the real world.

WHO WE PARTNER WITH

• U.S. & EU health, biotech, and AI innovators

• African governments & Ministries of Health

• GCC government entities and economic zones

• Diagnostics companies & manufacturers

• NGOs, donor agencies, and impact investors

• Private healthcare groups & hospitals

Each partnership is built around clarity, transparency, and measurable impact.

Thought Leadership On Medium

💡 Want to bring your innovation to the GCC or Africa?

360Disruption.com — Where Global Innovation Becomes National Impact

360Disruption is the execution engine behind some of the most ambitious expansions across the GCC and Africa.
We work with innovators, investors, and governments to commercialize breakthrough technologies, build sovereign capabilities, and open markets at national scale.

We are not consultants — we are partners in execution.
We don’t produce theory — we deliver operational outcomes.

From diagnostics to advanced manufacturing and AI-enabled infrastructure, 360Disruption turns vision into acceleration and strategy into momentum.

Build bigger. Scale faster. Execute with conviction.

📍 Cross-continental reach | Government partnerships | High-impact commercialization

👉 Ready to redefine your trajectory? Contact us today.

Made with Purpose and Precision by 360Disruption F.Z.E.
© 2026

Think Bigger. Move Faster. Disrupt Everything.

Global Reach | High-Impact Strategy | Market Domination